Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Preston

Showing results (461-470 of 764) with videos related to

Pageof 77
Sort By:
Radiation Research|December 4, 2003
Incidence of female breast cancer among atomic bomb survivors, Hiroshima and Nagasaki, 1950-1990Charles E Land, Masayoshi Tokunaga, Kojiro Koyama, et al.
Behavioural Pharmacology|April 21, 2004
Cyclazocine: comparison to hydromorphone and interaction with cocaineK L Preston, A Umbricht, J R Schroeder, et al.
Cancer Causes & Control : CCC|October 30, 1998
Skin tumor risk among atomic-bomb survivors in JapanE Ron, D L Preston, M Kishikawa, et al.
Molecular Pathology : MP|April 1, 2003
The new stem cell biology: something for everyoneS L Preston, M R Alison, S J Forbes, et al.
AIDS (London, England)|June 16, 2001
Pharmacokinetics and safety of amprenavir and ritonavir following multiple-dose, co-administration to healthy volunteersB M Sadler, P J Piliero, S L Preston, et al.
The Journal of Animal Ecology|December 28, 2020
Trematode parasites exceed aquatic insect biomass in Oregon stream food websDaniel L Preston, Tamara J Layden, Leah M Segui, et al.
Journal of Immunological Methods|February 24, 1989
Rapid assay and identification of human haemopoietic growth factorsW E Pullman, S Elsbury, M Kobayashi, et al.
American Journal of Speech-Language Pathology|June 7, 2019
Remediating Residual Rhotic Errors With Traditional and Ultrasound-Enhanced Treatment: A Single-Case Experimental StudyJonathan L Preston, Tara McAllister, Emily Phillips, et al.
Drug and Alcohol Dependence|October 21, 1999
Naltrexone shortened opioid detoxification with buprenorphineA Umbricht, I D Montoya, D R Hoover, et al.
The Journal of Infectious Diseases|March 10, 2001
Hollow-fiber unit evaluation of a new human immunodeficiency virus type 1 protease inhibitor, BMS-232632, for determination of the linked pharmacodynamic variableG L Drusano, J A Bilello, S L Preston, et al.
Pageof 77

Showing results (461-470 of 764) with videos related to

Sort By:
Pageof 77
Radiation Research|December 4, 2003
Incidence of female breast cancer among atomic bomb survivors, Hiroshima and Nagasaki, 1950-1990Charles E Land, Masayoshi Tokunaga, Kojiro Koyama, et al.
Behavioural Pharmacology|April 21, 2004
Cyclazocine: comparison to hydromorphone and interaction with cocaineK L Preston, A Umbricht, J R Schroeder, et al.
Cancer Causes & Control : CCC|October 30, 1998
Skin tumor risk among atomic-bomb survivors in JapanE Ron, D L Preston, M Kishikawa, et al.
Molecular Pathology : MP|April 1, 2003
The new stem cell biology: something for everyoneS L Preston, M R Alison, S J Forbes, et al.
AIDS (London, England)|June 16, 2001
Pharmacokinetics and safety of amprenavir and ritonavir following multiple-dose, co-administration to healthy volunteersB M Sadler, P J Piliero, S L Preston, et al.
The Journal of Animal Ecology|December 28, 2020
Trematode parasites exceed aquatic insect biomass in Oregon stream food websDaniel L Preston, Tamara J Layden, Leah M Segui, et al.
Journal of Immunological Methods|February 24, 1989
Rapid assay and identification of human haemopoietic growth factorsW E Pullman, S Elsbury, M Kobayashi, et al.
American Journal of Speech-Language Pathology|June 7, 2019
Remediating Residual Rhotic Errors With Traditional and Ultrasound-Enhanced Treatment: A Single-Case Experimental StudyJonathan L Preston, Tara McAllister, Emily Phillips, et al.
Drug and Alcohol Dependence|October 21, 1999
Naltrexone shortened opioid detoxification with buprenorphineA Umbricht, I D Montoya, D R Hoover, et al.
The Journal of Infectious Diseases|March 10, 2001
Hollow-fiber unit evaluation of a new human immunodeficiency virus type 1 protease inhibitor, BMS-232632, for determination of the linked pharmacodynamic variableG L Drusano, J A Bilello, S L Preston, et al.
Pageof 77